Neovasc Inc. (NVCN)

$6.56

-0.09 (-1.35%)
Rating:
Recommendation:
Buy
Symbol NVCN
Price $6.56
Beta 2.461
Volume Avg. 0.01M
Market Cap 17.745M
Shares () -
52 Week Range 4.59-20.5
1y Target Est -
DCF Unlevered NVCN DCF ->
DCF Levered NVCN LDCF ->
ROE -60.60% Strong Sell
ROA -54.76% Strong Sell
Operating Margin -
Debt / Equity 37.18% Neutral
P/E -
P/B 0.41 Neutral
Annual
Quarter

Earnings

Consensus EPS

Upgrades & Downgrades

Latest NVCN news


Mr. Fred Colen
Healthcare
Medical Devices
NASDAQ Capital Market

Neovasc Inc., a specialty medical device company, develops, manufactures, and markets products for cardiovascular marketplace in Europe and internationally. Its products include the Tiara technology for the transcatheter treatment of mitral valve disease; and the Neovasc Reducer for the treatment of refractory angina. The company was formerly known as Medical Ventures Corp. and changed its name to Neovasc Inc. in July 2008. Neovasc Inc. was incorporated in 2000 and is headquartered in Richmond, Canada.